Ian Shakil, CHIEF STRATEGY OFFICER at Augmedix, Inc. (AUGX), sold 219,922 shares at $4.11 ($909K) on 2024-04-03, disclosed to the SEC on 2024-04-04.
Scheduled sale ($909k) by CHIEF STRATEGY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.11 | 45,906 | $189K | 20.8% |
| 2 | $4.11 | 45,906 | $189K | 20.8% |
| 3 | $4.15 | 64,055 | $266K | 29.2% |
| 4 | $4.15 | 64,055 | $266K | 29.2% |
| Total | $4.13 avg | 219,922 | $909K | 100% |
| Filing → |
| AUGX | SELL | 2024-04-15 | $149K | — | Filing → |
| AUGX | SELL | 2024-04-11 | $738K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $678K | — | Filing → |